Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Silvio, Sandrini"'
Autor:
Piero Ruggenenti, Paolo Cravedi, Eliana Gotti, Annarita Plati, Maddalena Marasà, Silvio Sandrini, Nicola Bossini, Franco Citterio, Enrico Minetti, Domenico Montanaro, Ettore Sabadini, Regina Tardanico, Davide Martinetti, Flavio Gaspari, Alessandro Villa, Annalisa Perna, Francesco Peraro, Giuseppe Remuzzi
Publikováno v:
PLoS Medicine, Vol 18, Iss 6, p e1003668 (2021)
BackgroundWe compared protection of mycophenolate mofetil (MMF) and azathioprine (AZA) against acute cellular rejection (ACR) and chronic allograft nephropathy (CAN) in kidney transplant recipients on steroid-free, low-dose cyclosporine (CsA) microem
Externí odkaz:
https://doaj.org/article/30a39c55f59b4510a7e3ebcf1fd81bf6
Publikováno v:
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. 38(Suppl 77)
Steroid minimization has always been one of the most desired goals regarding immunosuppressive therapy after renal transplantation. Following the introduction of cyclosporine different steroid-free protocols became available, but their implementation
Autor:
Franco Citterio, Eliana Gotti, Giuseppe Remuzzi, Paolo Cravedi, Piero Ruggenenti, Regina Tardanico, Flavio Gaspari, Maddalena Marasa, Annarita Plati, Alessandro Villa, Ettore Sabadini, Annalisa Perna, Silvio Sandrini, Nicola Bossini, Domenico Montanaro, Francesco Peraro, Enrico Eugenio Minetti, Davide Martinetti
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 18, Iss 6, p e1003668 (2021)
PLoS Medicine, Vol 18, Iss 6, p e1003668 (2021)
Background We compared protection of mycophenolate mofetil (MMF) and azathioprine (AZA) against acute cellular rejection (ACR) and chronic allograft nephropathy (CAN) in kidney transplant recipients on steroid-free, low-dose cyclosporine (CsA) microe
Autor:
Silvio Sandrini, Francesco Scolari, Simona Fisogni, Roberta Cortinovis, Camilla Maffei, Franco Nodari, Nicola Bossini, Alberto Malagoli, Francesca Valerio
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims In renal transplant field, the progressive increase both of donor and recipient age has led further challenges in patient management. In this setting, the personalization of immunosuppressive therapies (IT) has been strongly sugge
Autor:
Alessandra Palmisano, Giampiero Girolomoni, Luigino Boschiero, Piergiorgio Messa, E. Minetti, Silvio Sandrini, Umberto Maggiore, Michele Rossini, Eliana Gotti, Irene Capelli, Francesco Nacchia, Gianluigi Zaza, Gianpaolo Tessari, Luigi Naldi, Rostand Emmanuel Nguefouet Momo, Mariarosaria Campise
Publikováno v:
Journal of nephrology. 33(6)
The impact of cancer on death of elderly kidney transplant recipients has been extensively investigated, but with conflicting results. Unlike their younger counterparts, in elderly kidney transplant recipients cardiovascular and infectious disease ma
Autor:
Alessia Gennarini, Paolo Cravedi, Maddalena Marasà, Annalisa Perna, Giovanni Rota, Mario Bontempelli, Silvio Sandrini, Giuseppe Remuzzi, Piero Ruggenenti
Publikováno v:
Journal of Transplantation, Vol 2012 (2012)
Dual induction with low doses of rabbit anti-human thymoglobulin (RATG) and basiliximab effectively and safely prevented allograft rejection in high-risk renal transplant recipients. To assess whether treatment timing affects efficacy and tolerabilit
Externí odkaz:
https://doaj.org/article/54d0c150ad2e4614a930027c7d4549cc
Autor:
Diana Verdirosi, Giovanni Cancarini, Valentina Mazzucotelli, Pierluca Piselli, Silvio Sandrini, Claudia Cimaglia, Diego Serraino
Publikováno v:
Journal of Nephrology. 30:851-857
Kidney transplant recipients (KTR) are known to have a higher risk of cancer than the general population, especially of malignancies related to oncogenic viral infections. This study assessed the incidence of de novo malignancies (DNMs) in patients r
Autor:
A. Corvo, Gianpaolo Tessari, A. Lupo, Silvio Sandrini, Loreto Gesualdo, Chiara Caletti, E. Minetti, Gianluigi Zaza, Giampiero Girolomoni, Irene Capelli, Luigino Boschiero, P. Manuel Ferraro
Background: Although optimization of immunosuppressive schemes in renal transplantation have minimized acute posttransplant complications, long-term outcomes are still not optimal and most of the chronic graft damage is drug-related. Therefore, to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ee9256b6424c6ecb1e0f3484711a376
http://hdl.handle.net/11585/678397
http://hdl.handle.net/11585/678397
Autor:
Mario Carmellini, Antonio Secchi, Tommaso Maria Manzia, Paola Todeschini, Gian Benedetto Piredda, Gianni Cappelli, Giuseppe Tisone, E. Minetti, Silvio Sandrini, Gionata Spagnoletti, Francesco Pisani, Lucrezia Furian
Publikováno v:
Transplantation
Background The risk of wound healing complications (WHCs) and the early use of mammalian target of rapamycin inhibitors after kidney transplantation (KT) have not been fully addressed. Methods The NEVERWOUND study is a 3-month, multicenter, randomize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c7900323fa141c9a982d898f456efbe
Autor:
Daniela Vallerini, Patrizia Barozzi, Chiara Quadrelli, Raffaella Bosco, Leonardo Potenza, Giovanni Riva, Gina Gregorini, Silvio Sandrini, Andrea Tironi, Giuliano Montagnani, Marisa De Palma, Giuseppe Torelli, Eric Delwart, Mario Luppi
Publikováno v:
Emerging Infectious Diseases, Vol 14, Iss 1, Pp 185-186 (2008)
Externí odkaz:
https://doaj.org/article/a31d0b35a3f14bbfa7f623cef4125760